Awardee OrganizationUNIVERSITY OF MIAMI SCHOOL OF MEDICINE
Description
Abstract Text
The University of Miami proposes to participate as a clinical center in
the African American Study of Kidney Disease (AASK) to compare the
efficacy of double-masked administration of randomized antihypertensive
drugs on blood pressure control and progressive renal disease.
A team of physicians and paramedical personnel, most of whom were involved
in the NIH sponsored Modification of Diet in Renal Disease Study and
experienced in the longterm care of patients with hypertension and renal
disease, is committed to an effective conduct of the Study. An
administrative center within the Division of Nephrology and an outpatient
clinic center will be dedicated to the AASK Miami team. The Clinical
Research Center will be used for patients requiring hospitalization.
Laboratory, pharmacy and radiopharmacy support will be provided by the
University of Miami Hospital and Clinics.
Potentially eligible African-American men and women can be identified on-
campus from the Renal and Hypertension, General Medicine, and family
Medicine Clinics at the University of Miami/Jackson Memorial Medical
Center, and the Renal and Hypertension Clinics at the Miami Veterans
Administration Medical Center, and the Clinics of UM Care and Jackson
Memorial Medical Center Health Plans. Enrollment of patients will also be
sought off-campus from nephrologists in practice, the Association of Black
Cardiologists, the Dade County Medical Association, local HMO's, family
medicine practice groups, and directly, through local advertisement within
the African-American community through newspapers, radio, television,
churches, social organizations, and the Dade County School District. The
population available and the interest in the Study by patients and
physicians alike indicate that 65 selected volunteer patients with
hypertension and chronic renal disease from arteriolar nephrosclerosis can
be entered, randomized and followed in Miami. The Miami team is committed
to accept and implement the common protocol and procedures approved by the
Steering Committee and NIDDK staff.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
052780918
UEI
F8THLJQSAF93
Project Start Date
15-August-1994
Project End Date
30-June-2001
Budget Start Date
15-August-1994
Budget End Date
30-June-1995
Project Funding Information for 1994
Total Funding
$299,254
Direct Costs
$194,954
Indirect Costs
$104,300
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Diabetes and Digestive and Kidney Diseases
$299,254
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U01DK048652-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U01DK048652-01
Patents
No Patents information available for 1U01DK048652-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U01DK048652-01
Clinical Studies
No Clinical Studies information available for 1U01DK048652-01
News and More
Related News Releases
No news release information available for 1U01DK048652-01
History
No Historical information available for 1U01DK048652-01
Similar Projects
No Similar Projects information available for 1U01DK048652-01